Sodium alendronate: proposal and reliability of indicators

Detalhes bibliográficos
Autor(a) principal: Silva, Ricardo Augusto dos Santos
Data de Publicação: 2022
Outros Autores: Baldoni, Andre Oliveira, Alvim, Camila Pereira, Obreli-Neto, Paulo Roque, Guidoni, Camilo Molino, Silva, Isabella Ribeiro, Figueiredo, Roberta Carvalho
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Journal of Pharmaceutical Sciences
DOI: 10.1590/s2175-97902022e19193
Texto Completo: https://www.revistas.usp.br/bjps/article/view/204496
Resumo: The present study proposes and evaluates the test-retest reliability of indicators of the correct use of sodium alendronate in elderly patients. This is a test-retest reliability study for use of sodium alendronate. Six questions to evaluate the correct use of this medicine were elaborated after analysis of information in the literature. Data collection was performed through questionnaires in face-to-face in-home interviews by previously trained interviewers. The participants were initially interviewed (test) when they agreed to participate in the study, and secondly (retest), after a period of 7 to 14 days from the first interview. The reliability of the questions was evaluated by means of the agreement percentage and the Kappa coefficient. Fifty-seven pairs (test-retest) were obtained. The mean age was 69.3 (SD = 6.9) years, the majority (92.5%) completed elementary education, and declared themselves white (50.9%). All the questions presented high concordance ranging from 79.0% to 98.3%. The Kappa values ranged from 0.1 (low) to 0.83 (very good). The agreement percentage and the Kappa values suggest adequate reliability of the proposed questions. We suggest that they can be used as a simple and quick way to evaluate the quality of sodium alendronate use among the elderly.
id USP-31_f4275912c23446c513973b783c6be832
oai_identifier_str oai:revistas.usp.br:article/204496
network_acronym_str USP-31
network_name_str Brazilian Journal of Pharmaceutical Sciences
spelling Sodium alendronate: proposal and reliability of indicatorsDrug utilizationAlendronateOsteoporosis PostmenopausalThe present study proposes and evaluates the test-retest reliability of indicators of the correct use of sodium alendronate in elderly patients. This is a test-retest reliability study for use of sodium alendronate. Six questions to evaluate the correct use of this medicine were elaborated after analysis of information in the literature. Data collection was performed through questionnaires in face-to-face in-home interviews by previously trained interviewers. The participants were initially interviewed (test) when they agreed to participate in the study, and secondly (retest), after a period of 7 to 14 days from the first interview. The reliability of the questions was evaluated by means of the agreement percentage and the Kappa coefficient. Fifty-seven pairs (test-retest) were obtained. The mean age was 69.3 (SD = 6.9) years, the majority (92.5%) completed elementary education, and declared themselves white (50.9%). All the questions presented high concordance ranging from 79.0% to 98.3%. The Kappa values ranged from 0.1 (low) to 0.83 (very good). The agreement percentage and the Kappa values suggest adequate reliability of the proposed questions. We suggest that they can be used as a simple and quick way to evaluate the quality of sodium alendronate use among the elderly.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2022-11-17info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/20449610.1590/s2175-97902022e19193Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/204496/194963Copyright (c) 2022 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSilva, Ricardo Augusto dos SantosBaldoni, Andre OliveiraAlvim, Camila PereiraObreli-Neto, Paulo RoqueGuidoni, Camilo MolinoSilva, Isabella RibeiroFigueiredo, Roberta Carvalho 2023-08-18T20:55:25Zoai:revistas.usp.br:article/204496Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-08-18T20:55:25Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false
dc.title.none.fl_str_mv Sodium alendronate: proposal and reliability of indicators
title Sodium alendronate: proposal and reliability of indicators
spellingShingle Sodium alendronate: proposal and reliability of indicators
Sodium alendronate: proposal and reliability of indicators
Silva, Ricardo Augusto dos Santos
Drug utilization
Alendronate
Osteoporosis
Postmenopausal
Silva, Ricardo Augusto dos Santos
Drug utilization
Alendronate
Osteoporosis
Postmenopausal
title_short Sodium alendronate: proposal and reliability of indicators
title_full Sodium alendronate: proposal and reliability of indicators
title_fullStr Sodium alendronate: proposal and reliability of indicators
Sodium alendronate: proposal and reliability of indicators
title_full_unstemmed Sodium alendronate: proposal and reliability of indicators
Sodium alendronate: proposal and reliability of indicators
title_sort Sodium alendronate: proposal and reliability of indicators
author Silva, Ricardo Augusto dos Santos
author_facet Silva, Ricardo Augusto dos Santos
Silva, Ricardo Augusto dos Santos
Baldoni, Andre Oliveira
Alvim, Camila Pereira
Obreli-Neto, Paulo Roque
Guidoni, Camilo Molino
Silva, Isabella Ribeiro
Figueiredo, Roberta Carvalho
Baldoni, Andre Oliveira
Alvim, Camila Pereira
Obreli-Neto, Paulo Roque
Guidoni, Camilo Molino
Silva, Isabella Ribeiro
Figueiredo, Roberta Carvalho
author_role author
author2 Baldoni, Andre Oliveira
Alvim, Camila Pereira
Obreli-Neto, Paulo Roque
Guidoni, Camilo Molino
Silva, Isabella Ribeiro
Figueiredo, Roberta Carvalho
author2_role author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva, Ricardo Augusto dos Santos
Baldoni, Andre Oliveira
Alvim, Camila Pereira
Obreli-Neto, Paulo Roque
Guidoni, Camilo Molino
Silva, Isabella Ribeiro
Figueiredo, Roberta Carvalho
dc.subject.por.fl_str_mv Drug utilization
Alendronate
Osteoporosis
Postmenopausal
topic Drug utilization
Alendronate
Osteoporosis
Postmenopausal
description The present study proposes and evaluates the test-retest reliability of indicators of the correct use of sodium alendronate in elderly patients. This is a test-retest reliability study for use of sodium alendronate. Six questions to evaluate the correct use of this medicine were elaborated after analysis of information in the literature. Data collection was performed through questionnaires in face-to-face in-home interviews by previously trained interviewers. The participants were initially interviewed (test) when they agreed to participate in the study, and secondly (retest), after a period of 7 to 14 days from the first interview. The reliability of the questions was evaluated by means of the agreement percentage and the Kappa coefficient. Fifty-seven pairs (test-retest) were obtained. The mean age was 69.3 (SD = 6.9) years, the majority (92.5%) completed elementary education, and declared themselves white (50.9%). All the questions presented high concordance ranging from 79.0% to 98.3%. The Kappa values ranged from 0.1 (low) to 0.83 (very good). The agreement percentage and the Kappa values suggest adequate reliability of the proposed questions. We suggest that they can be used as a simple and quick way to evaluate the quality of sodium alendronate use among the elderly.
publishDate 2022
dc.date.none.fl_str_mv 2022-11-17
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://www.revistas.usp.br/bjps/article/view/204496
10.1590/s2175-97902022e19193
url https://www.revistas.usp.br/bjps/article/view/204496
identifier_str_mv 10.1590/s2175-97902022e19193
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv https://www.revistas.usp.br/bjps/article/view/204496/194963
dc.rights.driver.fl_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2022 Brazilian Journal of Pharmaceutical Sciences
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
publisher.none.fl_str_mv Universidade de São Paulo. Faculdade de Ciências Farmacêuticas
dc.source.none.fl_str_mv Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; v. 58 (2022)
Brazilian Journal of Pharmaceutical Sciences; Vol. 58 (2022)
2175-9790
1984-8250
reponame:Brazilian Journal of Pharmaceutical Sciences
instname:Universidade de São Paulo (USP)
instacron:USP
instname_str Universidade de São Paulo (USP)
instacron_str USP
institution USP
reponame_str Brazilian Journal of Pharmaceutical Sciences
collection Brazilian Journal of Pharmaceutical Sciences
repository.name.fl_str_mv Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)
repository.mail.fl_str_mv bjps@usp.br||elizabeth.igne@gmail.com
_version_ 1822179249489969152
dc.identifier.doi.none.fl_str_mv 10.1590/s2175-97902022e19193